Illumina, Inc. (ILMN) issued an update on its FY12 earnings guidance on Tuesday morning. The company provided EPS guidance of $1.54-1.59 for the period.

Shares of Illumina, Inc. (ILMN) traded down 3.07% during mid-day trading on Tuesday, hitting $45.19. Illumina, Inc. (ILMN) has a 52 week low of $25.65 and a 52 week high of $55.39. The company has a market cap of $5.558 billion and a P/E ratio of 75.93.

Illumina last announced its earnings results on Tuesday, October 23rd. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.02. The company’s quarterly revenue was up 21.4% on a year-over-year basis. On average, analysts predict that Illumina, Inc. (ILMN) will post $1.57 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on ILMN shares. Analysts at Credit Suisse reiterated an outperform rating on shares of Illumina in a research note to investors on Friday, October 5th. They now have a $55.00 price target on the stock. On a related note, analysts at Credit Agricole upgraded shares of Illumina from a sell rating to an outperform rating in a research note to investors on Wednesday, July 25th. Finally, analysts at Credit Agricole upgraded shares of Illumina from a sell rating to an outperform rating in a research note to investors on Wednesday, July 25th.

Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.